Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 402 entries
Sorted by: Best Match Show Resources per page
Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer.

Frontiers in oncology

Rabinowits G, Bowden M, Flores LM, Verselis S, Vergara V, Jo VY, Chau N, Lorch J, Hammerman PS, Thomas T, Goguen LA, Annino D, Schoenfeld JD, Margalit DN, Tishler RB, Haddad RI.
PMID: 28900608
Front Oncol. 2017 Aug 29;7:191. doi: 10.3389/fonc.2017.00191. eCollection 2017.

BACKGROUND: Identification of a microRNA (miRNA) pattern to be used as a biomarker for HNSCC is challenging given the heterogeneity of the disease and different methodologies used. To better define the field, we performed a prospective analysis of blood,...

Cite
Rabinowits G, Bowden M, Flores LM, et al. Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer. Front Oncol. 2017;7:191doi: 10.3389/fonc.2017.00191.
Rabinowits, G., Bowden, M., Flores, L. M., Verselis, S., Vergara, V., Jo, V. Y., Chau, N., Lorch, J., Hammerman, P. S., Thomas, T., Goguen, L. A., Annino, D., Schoenfeld, J. D., Margalit, D. N., Tishler, R. B., & Haddad, R. I. (2017). Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer. Frontiers in oncology, 7191. https://doi.org/10.3389/fonc.2017.00191
Rabinowits, Guilherme, et al. "Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer." Frontiers in oncology vol. 7 (2017): 191. doi: https://doi.org/10.3389/fonc.2017.00191
Rabinowits G, Bowden M, Flores LM, Verselis S, Vergara V, Jo VY, Chau N, Lorch J, Hammerman PS, Thomas T, Goguen LA, Annino D, Schoenfeld JD, Margalit DN, Tishler RB, Haddad RI. Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer. Front Oncol. 2017 Aug 29;7:191. doi: 10.3389/fonc.2017.00191. eCollection 2017. PMID: 28900608; PMCID: PMC5581802.
Copy Download .nbib Format: NLM
AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism.

Molecular therapy. Nucleic acids

Rech M, Kuhn AR, Lumens J, Carai P, van Leeuwen R, Verhesen W, Verjans R, Lecomte J, Liu Y, Luiken JJFP, Mohren R, Cillero-Pastor B, Heymans S, Knoops K, van Bilsen M, Schroen B.
PMID: 30731323
Mol Ther Nucleic Acids. 2019 Mar 01;14:424-437. doi: 10.1016/j.omtn.2018.12.010. Epub 2018 Dec 22.

MicroRNA-103/107 regulate systemic glucose metabolism and insulin sensitivity. For this reason, inhibitory strategies for these microRNAs are currently being tested in clinical trials. Given the high metabolic demands of the heart and the abundant cardiac expression of miR-103/107, we...

Cite
Rech M, Kuhn AR, Lumens J, et al. AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Mol Ther Nucleic Acids. 2018;14:424-437doi: 10.1016/j.omtn.2018.12.010.
Rech, M., Kuhn, A. R., Lumens, J., Carai, P., van Leeuwen, R., Verhesen, W., Verjans, R., Lecomte, J., Liu, Y., Luiken, J. J. F. P., Mohren, R., Cillero-Pastor, B., Heymans, S., Knoops, K., van Bilsen, M., & Schroen, B. (2019). AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Molecular therapy. Nucleic acids, 14424-437. https://doi.org/10.1016/j.omtn.2018.12.010
Rech, Monika, et al. "AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism." Molecular therapy. Nucleic acids vol. 14 (2019): 424-437. doi: https://doi.org/10.1016/j.omtn.2018.12.010
Rech M, Kuhn AR, Lumens J, Carai P, van Leeuwen R, Verhesen W, Verjans R, Lecomte J, Liu Y, Luiken JJFP, Mohren R, Cillero-Pastor B, Heymans S, Knoops K, van Bilsen M, Schroen B. AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Mol Ther Nucleic Acids. 2019 Mar 01;14:424-437. doi: 10.1016/j.omtn.2018.12.010. Epub 2018 Dec 22. PMID: 30731323; PMCID: PMC6365487.
Copy Download .nbib Format: NLM
Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study.

The open nursing journal

Kisch AM, Forsberg A.
PMID: 29844844
Open Nurs J. 2018 Mar 30;12:46-57. doi: 10.2174/1874434601812010046. eCollection 2018.

BACKGROUND: There is limited knowledge about the perspective of patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) about having a sibling as donor. It is essential to understand the main concerns of stem cell recipients in order to enable...

Cite
Kisch AM, Forsberg A. Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study. Open Nurs J. 2018;12:46-57doi: 10.2174/1874434601812010046.
Kisch, A. M., & Forsberg, A. (2018). Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study. The open nursing journal, 1246-57. https://doi.org/10.2174/1874434601812010046
Kisch, Annika M, and Forsberg, Anna. "Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study." The open nursing journal vol. 12 (2018): 46-57. doi: https://doi.org/10.2174/1874434601812010046
Kisch AM, Forsberg A. Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study. Open Nurs J. 2018 Mar 30;12:46-57. doi: 10.2174/1874434601812010046. eCollection 2018. PMID: 29844844; PMCID: PMC5897957.
Copy Download .nbib Format: NLM
A novel phase function describing light scattering of layers containing colloidal nanospheres.

Nanoscale

Wang J, Xu C, Nilsson AM, Fernandes DLA, Niklasson GA.
PMID: 30938744
Nanoscale. 2019 Apr 11;11(15):7404-7413. doi: 10.1039/c9nr01707k.

Light scattering from small particles exhibit unique angular scattering distributions, which are strongly dependent on the radius to wavelength ratio as well as the refractive index contrast between the particles and the surrounding medium. As the concentration of the...

Cite
Wang J, Xu C, Nilsson AM, et al. A novel phase function describing light scattering of layers containing colloidal nanospheres. Nanoscale. 2019;11(15):7404-7413doi: 10.1039/c9nr01707k.
Wang, J., Xu, C., Nilsson, A. M., Fernandes, D. L. A., & Niklasson, G. A. (2019). A novel phase function describing light scattering of layers containing colloidal nanospheres. Nanoscale, 11(15), 7404-7413. https://doi.org/10.1039/c9nr01707k
Wang, Junxin, et al. "A novel phase function describing light scattering of layers containing colloidal nanospheres." Nanoscale vol. 11,15 (2019): 7404-7413. doi: https://doi.org/10.1039/c9nr01707k
Wang J, Xu C, Nilsson AM, Fernandes DLA, Niklasson GA. A novel phase function describing light scattering of layers containing colloidal nanospheres. Nanoscale. 2019 Apr 11;11(15):7404-7413. doi: 10.1039/c9nr01707k. PMID: 30938744.
Copy Download .nbib Format: NLM
Improving Docking Performance Using Negative Image-Based Rescoring.

Frontiers in pharmacology

Kurkinen ST, Niinivehmas S, Ahinko M, Lätti S, Pentikäinen OT, Postila PA.
PMID: 29632488
Front Pharmacol. 2018 Mar 26;9:260. doi: 10.3389/fphar.2018.00260. eCollection 2018.

Despite the large computational costs of molecular docking, the default scoring functions are often unable to recognize the active hits from the inactive molecules in large-scale virtual screening experiments. Thus, even though a correct binding pose might be sampled...

Cite
Kurkinen ST, Niinivehmas S, Ahinko M, et al. Improving Docking Performance Using Negative Image-Based Rescoring. Front Pharmacol. 2018;9:260doi: 10.3389/fphar.2018.00260.
Kurkinen, S. T., Niinivehmas, S., Ahinko, M., Lätti, S., Pentikäinen, O. T., & Postila, P. A. (2018). Improving Docking Performance Using Negative Image-Based Rescoring. Frontiers in pharmacology, 9260. https://doi.org/10.3389/fphar.2018.00260
Kurkinen, Sami T, et al. "Improving Docking Performance Using Negative Image-Based Rescoring." Frontiers in pharmacology vol. 9 (2018): 260. doi: https://doi.org/10.3389/fphar.2018.00260
Kurkinen ST, Niinivehmas S, Ahinko M, Lätti S, Pentikäinen OT, Postila PA. Improving Docking Performance Using Negative Image-Based Rescoring. Front Pharmacol. 2018 Mar 26;9:260. doi: 10.3389/fphar.2018.00260. eCollection 2018. PMID: 29632488; PMCID: PMC5879118.
Copy Download .nbib Format: NLM
Determination of Withanolides in .

Journal of AOAC International

Koshy R, Anand MS, Murali B, Brunelle SL, Sullivan DM, Bzhelyansky A, Es-Safi NE, Ingle P, Phillips T, Sayre C, Rimmer C, Solyom AM, Young K, Zhang Y, Coates SG.
PMID: 28825556
J AOAC Int. 2017 Jan 01;100(1):277-279. doi: 10.5740/jaoacint.2015.17.

No abstract available.

Cite
Koshy R, Anand MS, Murali B, et al. Determination of Withanolides in . J AOAC Int. 2017;100(1):277-279doi: 10.5740/jaoacint.2015.17.
Koshy, R., Anand, M. S., Murali, B., Brunelle, S. L., Sullivan, D. M., Bzhelyansky, A., Es-Safi, N. E., Ingle, P., Phillips, T., Sayre, C., Rimmer, C., Solyom, A. M., Young, K., Zhang, Y., & Coates, S. G. (2017). Determination of Withanolides in . Journal of AOAC International, 100(1), 277-279. https://doi.org/10.5740/jaoacint.2015.17
Koshy, Rojison, et al. "Determination of Withanolides in ." Journal of AOAC International vol. 100,1 (2017): 277-279. doi: https://doi.org/10.5740/jaoacint.2015.17
Koshy R, Anand MS, Murali B, Brunelle SL, Sullivan DM, Bzhelyansky A, Es-Safi NE, Ingle P, Phillips T, Sayre C, Rimmer C, Solyom AM, Young K, Zhang Y, Coates SG. Determination of Withanolides in . J AOAC Int. 2017 Jan 01;100(1):277-279. doi: 10.5740/jaoacint.2015.17. PMID: 28825556.
Copy Download .nbib Format: NLM
Severe consequences of habitat fragmentation on genetic diversity of an endangered Australian freshwater fish: A call for assisted gene flow.

Evolutionary applications

Pavlova A, Beheregaray LB, Coleman R, Gilligan D, Harrisson KA, Ingram BA, Kearns J, Lamb AM, Lintermans M, Lyon J, Nguyen TTT, Sasaki M, Tonkin Z, Yen JDL, Sunnucks P.
PMID: 28616062
Evol Appl. 2017 May 11;10(6):531-550. doi: 10.1111/eva.12484. eCollection 2017 Jul.

Genetic diversity underpins the ability of populations to persist and adapt to environmental changes. Substantial empirical data show that genetic diversity rapidly deteriorates in small and isolated populations due to genetic drift, leading to reduction in adaptive potential and...

Cite
Pavlova A, Beheregaray LB, Coleman R, et al. Severe consequences of habitat fragmentation on genetic diversity of an endangered Australian freshwater fish: A call for assisted gene flow. Evol Appl. 2017;10(6):531-550doi: 10.1111/eva.12484.
Pavlova, A., Beheregaray, L. B., Coleman, R., Gilligan, D., Harrisson, K. A., Ingram, B. A., Kearns, J., Lamb, A. M., Lintermans, M., Lyon, J., Nguyen, T. T. T., Sasaki, M., Tonkin, Z., Yen, J. D. L., & Sunnucks, P. (2017). Severe consequences of habitat fragmentation on genetic diversity of an endangered Australian freshwater fish: A call for assisted gene flow. Evolutionary applications, 10(6), 531-550. https://doi.org/10.1111/eva.12484
Pavlova, Alexandra, et al. "Severe consequences of habitat fragmentation on genetic diversity of an endangered Australian freshwater fish: A call for assisted gene flow." Evolutionary applications vol. 10,6 (2017): 531-550. doi: https://doi.org/10.1111/eva.12484
Pavlova A, Beheregaray LB, Coleman R, Gilligan D, Harrisson KA, Ingram BA, Kearns J, Lamb AM, Lintermans M, Lyon J, Nguyen TTT, Sasaki M, Tonkin Z, Yen JDL, Sunnucks P. Severe consequences of habitat fragmentation on genetic diversity of an endangered Australian freshwater fish: A call for assisted gene flow. Evol Appl. 2017 May 11;10(6):531-550. doi: 10.1111/eva.12484. eCollection 2017 Jul. PMID: 28616062; PMCID: PMC5469170.
Copy Download .nbib Format: NLM
Psychotropic medication use in autism spectrum disorders may affect functional brain connectivity.

Biological psychiatry. Cognitive neuroscience and neuroimaging

Linke AC, Olson L, Gao Y, Fishman I, Müller RA.
PMID: 29104944
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Sep;2(6):518-527. doi: 10.1016/j.bpsc.2017.06.008.

BACKGROUND: Prescription of psychotropic medications is common in autism spectrum disorders (ASDs), either off-label or to treat comorbid conditions such as ADHD or depression. Psychotropic medications are intended to alter brain function. Yet, studies investigating the functional brain organization...

Cite
Linke AC, Olson L, Gao Y, et al. Psychotropic medication use in autism spectrum disorders may affect functional brain connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(6):518-527doi: 10.1016/j.bpsc.2017.06.008.
Linke, A. C., Olson, L., Gao, Y., Fishman, I., & Müller, R. A. (2017). Psychotropic medication use in autism spectrum disorders may affect functional brain connectivity. Biological psychiatry. Cognitive neuroscience and neuroimaging, 2(6), 518-527. https://doi.org/10.1016/j.bpsc.2017.06.008
Linke, Annika C, et al. "Psychotropic medication use in autism spectrum disorders may affect functional brain connectivity." Biological psychiatry. Cognitive neuroscience and neuroimaging vol. 2,6 (2017): 518-527. doi: https://doi.org/10.1016/j.bpsc.2017.06.008
Linke AC, Olson L, Gao Y, Fishman I, Müller RA. Psychotropic medication use in autism spectrum disorders may affect functional brain connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Sep;2(6):518-527. doi: 10.1016/j.bpsc.2017.06.008. PMID: 29104944; PMCID: PMC5667652.
Copy Download .nbib Format: NLM
Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands.

Sarcoma

van Broekhoven DLM, Verschoor AJ, van Dalen T, Grünhagen DJ, den Bakker MA, Gelderblom H, Bovee JVMG, Haas RLM, Bonenkamp HJ, van Coevorden F, Ten Oever D, van der Graaf WTA, Flucke UE, Pras E, Reyners AKL, Westermann AM, Oldenburger F, Verhoef C, Steeghs N.
PMID: 30034268
Sarcoma. 2018 Jun 21;2018:5982575. doi: 10.1155/2018/5982575. eCollection 2018.

INTRODUCTION: Nonsurgical management of patients with desmoid-type fibromatosis (DF) is increasing. This study tries to provide insight on type, usage, and outcome of first-line nonsurgical management strategies.PATIENTS AND METHODS: From the Dutch Pathology Registry (PALGA), patients with extra-abdominal or...

Cite
van Broekhoven DLM, Verschoor AJ, van Dalen T, et al. Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands. Sarcoma. 2018;2018:5982575doi: 10.1155/2018/5982575.
van Broekhoven, D. L. M., Verschoor, A. J., van Dalen, T., Grünhagen, D. J., den Bakker, M. A., Gelderblom, H., Bovee, J. V. M. G., Haas, R. L. M., Bonenkamp, H. J., van Coevorden, F., Ten Oever, D., van der Graaf, W. T. A., Flucke, U. E., Pras, E., Reyners, A. K. L., Westermann, A. M., Oldenburger, F., Verhoef, C., & Steeghs, N. (2018). Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands. Sarcoma, 20185982575. https://doi.org/10.1155/2018/5982575
van Broekhoven, Danique L M, et al. "Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands." Sarcoma vol. 2018 (2018): 5982575. doi: https://doi.org/10.1155/2018/5982575
van Broekhoven DLM, Verschoor AJ, van Dalen T, Grünhagen DJ, den Bakker MA, Gelderblom H, Bovee JVMG, Haas RLM, Bonenkamp HJ, van Coevorden F, Ten Oever D, van der Graaf WTA, Flucke UE, Pras E, Reyners AKL, Westermann AM, Oldenburger F, Verhoef C, Steeghs N. Outcome of Nonsurgical Management of Extra-Abdominal, Trunk, and Abdominal Wall Desmoid-Type Fibromatosis: A Population-Based Study in the Netherlands. Sarcoma. 2018 Jun 21;2018:5982575. doi: 10.1155/2018/5982575. eCollection 2018. PMID: 30034268; PMCID: PMC6032644.
Copy Download .nbib Format: NLM
Andreev spectrum and supercurrents in nanowire-based SNS junctions containing Majorana bound states.

Beilstein journal of nanotechnology

Cayao J, Black-Schaffer AM, Prada E, Aguado R.
PMID: 29977669
Beilstein J Nanotechnol. 2018 May 03;9:1339-1357. doi: 10.3762/bjnano.9.127. eCollection 2018.

Hybrid superconductor-semiconductor nanowires with Rashba spin-orbit coupling are arguably becoming the leading platform for the search of Majorana bound states (MBSs) in engineered topological superconductors. We perform a systematic numerical study of the low-energy Andreev spectrum and supercurrents in...

Cite
Cayao J, Black-Schaffer AM, Prada E, et al. Andreev spectrum and supercurrents in nanowire-based SNS junctions containing Majorana bound states. Beilstein J Nanotechnol. 2018;9:1339-1357doi: 10.3762/bjnano.9.127.
Cayao, J., Black-Schaffer, A. M., Prada, E., & Aguado, R. (2018). Andreev spectrum and supercurrents in nanowire-based SNS junctions containing Majorana bound states. Beilstein journal of nanotechnology, 91339-1357. https://doi.org/10.3762/bjnano.9.127
Cayao, Jorge, et al. "Andreev spectrum and supercurrents in nanowire-based SNS junctions containing Majorana bound states." Beilstein journal of nanotechnology vol. 9 (2018): 1339-1357. doi: https://doi.org/10.3762/bjnano.9.127
Cayao J, Black-Schaffer AM, Prada E, Aguado R. Andreev spectrum and supercurrents in nanowire-based SNS junctions containing Majorana bound states. Beilstein J Nanotechnol. 2018 May 03;9:1339-1357. doi: 10.3762/bjnano.9.127. eCollection 2018. PMID: 29977669; PMCID: PMC6009489.
Copy Download .nbib Format: NLM
AOAC SMPR® 2017.009. Standard Method Performance Requirements (SMPRs) for Quantitation of Aloe Vera Characteristic Water-Soluble Main Constituents in Dietary Supplements.

Journal of AOAC International

Ingle P, Barrett B, Betz JM, Don C, Es-Safi NE, Griffiths J, Joseph G, Kennedy DC, Mudge E, Phillips MM, Phillips T, Richards LD, Rimmer CA, Schaneberg BT, Solyom AM, Sullivan DM, Traub J, Zhang Y, Zielinski G, Coates SG.
PMID: 28802312
J AOAC Int. 2017 Jul 01;100(4):1185-1186. doi: 10.5740/jaoacint.SMPR2017_009.

No abstract available.

Cite
Ingle P, Barrett B, Betz JM, et al. AOAC SMPR® 2017.009. Standard Method Performance Requirements (SMPRs) for Quantitation of Aloe Vera Characteristic Water-Soluble Main Constituents in Dietary Supplements. J AOAC Int. 2017;100(4):1185-1186doi: 10.5740/jaoacint.SMPR2017_009.
Ingle, P., Barrett, B., Betz, J. M., Don, C., Es-Safi, N. E., Griffiths, J., Joseph, G., Kennedy, D. C., Mudge, E., Phillips, M. M., Phillips, T., Richards, L. D., Rimmer, C. A., Schaneberg, B. T., Solyom, A. M., Sullivan, D. M., Traub, J., Zhang, Y., Zielinski, G., & Coates, S. G. (2017). AOAC SMPR® 2017.009. Standard Method Performance Requirements (SMPRs) for Quantitation of Aloe Vera Characteristic Water-Soluble Main Constituents in Dietary Supplements. Journal of AOAC International, 100(4), 1185-1186. https://doi.org/10.5740/jaoacint.SMPR2017_009
Ingle, Prashant, et al. "AOAC SMPR® 2017.009. Standard Method Performance Requirements (SMPRs) for Quantitation of Aloe Vera Characteristic Water-Soluble Main Constituents in Dietary Supplements." Journal of AOAC International vol. 100,4 (2017): 1185-1186. doi: https://doi.org/10.5740/jaoacint.SMPR2017_009
Ingle P, Barrett B, Betz JM, Don C, Es-Safi NE, Griffiths J, Joseph G, Kennedy DC, Mudge E, Phillips MM, Phillips T, Richards LD, Rimmer CA, Schaneberg BT, Solyom AM, Sullivan DM, Traub J, Zhang Y, Zielinski G, Coates SG. AOAC SMPR® 2017.009. Standard Method Performance Requirements (SMPRs) for Quantitation of Aloe Vera Characteristic Water-Soluble Main Constituents in Dietary Supplements. J AOAC Int. 2017 Jul 01;100(4):1185-1186. doi: 10.5740/jaoacint.SMPR2017_009. PMID: 28802312.
Copy Download .nbib Format: NLM
AOAC SMPR® 2017.010. Standard Method Performance Requirements (SMPRs) for Identification of Aloe Vera in Dietary Supplements and Dietary Ingredients.

Journal of AOAC International

Ingle P, Barrett B, Betz JM, Don C, Es-Safi NE, Griffiths J, Joseph G, Kennedy DC, Mudge E, Phillips MM, Phillips T, Richards LD, Rimmer CA, Schaneberg BT, Solyom AM, Sullivan DM, Traub J, Zhang Y, Zielinski G, Coates SG.
PMID: 28802313
J AOAC Int. 2017 Jul 01;100(4):1187-1188. doi: 10.5740/jaoacint.SMPR2017_010.

No abstract available.

Cite
Ingle P, Barrett B, Betz JM, et al. AOAC SMPR® 2017.010. Standard Method Performance Requirements (SMPRs) for Identification of Aloe Vera in Dietary Supplements and Dietary Ingredients. J AOAC Int. 2017;100(4):1187-1188doi: 10.5740/jaoacint.SMPR2017_010.
Ingle, P., Barrett, B., Betz, J. M., Don, C., Es-Safi, N. E., Griffiths, J., Joseph, G., Kennedy, D. C., Mudge, E., Phillips, M. M., Phillips, T., Richards, L. D., Rimmer, C. A., Schaneberg, B. T., Solyom, A. M., Sullivan, D. M., Traub, J., Zhang, Y., Zielinski, G., & Coates, S. G. (2017). AOAC SMPR® 2017.010. Standard Method Performance Requirements (SMPRs) for Identification of Aloe Vera in Dietary Supplements and Dietary Ingredients. Journal of AOAC International, 100(4), 1187-1188. https://doi.org/10.5740/jaoacint.SMPR2017_010
Ingle, Prashant, et al. "AOAC SMPR® 2017.010. Standard Method Performance Requirements (SMPRs) for Identification of Aloe Vera in Dietary Supplements and Dietary Ingredients." Journal of AOAC International vol. 100,4 (2017): 1187-1188. doi: https://doi.org/10.5740/jaoacint.SMPR2017_010
Ingle P, Barrett B, Betz JM, Don C, Es-Safi NE, Griffiths J, Joseph G, Kennedy DC, Mudge E, Phillips MM, Phillips T, Richards LD, Rimmer CA, Schaneberg BT, Solyom AM, Sullivan DM, Traub J, Zhang Y, Zielinski G, Coates SG. AOAC SMPR® 2017.010. Standard Method Performance Requirements (SMPRs) for Identification of Aloe Vera in Dietary Supplements and Dietary Ingredients. J AOAC Int. 2017 Jul 01;100(4):1187-1188. doi: 10.5740/jaoacint.SMPR2017_010. PMID: 28802313.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 402 entries